Before the BPCA and PREA, the vast majority of drugs, more than 80 percent used in children were used off-label and without data on their safety or efficacy, and today that number has been reduced to approximately 50 percent, but that is still a lot.
Eshoo discusses the reduction of off-label drug use in children.
Share
More from Anna Eshoo
The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.
We need more guardrails in place on AI, which is why I introduced the Real Political Ads Act earlier this month.
I thank the ranking member of the full committee for yielding time. Today, the House is going to vote on my legislation, H.R. 3226, the PREEMIE Reauthorization Act. I thank the co-leads of this legislation: Representatives Miller-Meeks…
It is stunning to me that someone pays for something, they don't get it, but the person or the entity they paid it to still gets to keep it.
Other voices in this conversation
